The company closed its plan on December 29, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,100 KRW | +0.36% |
|
+0.54% | +1.26% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.26% | 120M | |
+24.53% | 45.07B | |
+30.99% | 23.39B | |
+24.13% | 16.08B | |
+21.15% | 14.6B | |
+68.67% | 14.01B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.53% | 5.64B | |
+10.74% | 4.89B |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback announced on September 28, 2022, has closed with 120,000 shares, representing 2% for KRW 3,418.04 million.